ロード中...
Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study
BACKGROUND: A total of 50 million persons were diagnosed worldwide with epilepsy. One-third of them are experiencing debilitating seizures despite optimum anti‐epileptic drugs (AEDs) treatment. Several studies have suggested that CYP3A5, CHRM2, and ZNF498 influence the pharmacokinetics of AEDs. Ther...
保存先:
| 出版年: | Pharmgenomics Pers Med |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6732506/ https://ncbi.nlm.nih.gov/pubmed/31564953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S212433 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|